The new venture, called MBX Biosciences Inc., aims to develop therapeutics to treat rare endocrine disorders. The company has already raised $2.5 million in funding.
Capitol Village Healthcare, a 52-bed nursing home at 2926 N. Capitol Ave., closed earlier this year, and had received low ratings from U.S. News and the Centers for Medicare & Medicaid Services.
The annual rankings, now in their 30th year, are designed to assist patients and their doctors in making decisions about where to get care.
The move is part of IU Health’s way to address the state’s high infant mortality rate and keep all newborn services under one roof.
Jack Phillips, who has led Roche Diagnostics’ North American operations in Indianapolis since 2010, will become chief operating officer of Accelerate Diagnostics in Tucson.
An Indianapolis-based real estate company that specializes in health care properties has acquired more than 300,000 square feet of commercial office space on the city’s northeast side, including the headquarters of Community Health Network.
The company has been bleeding red ink, but its Medicare business is booming and could ring up nearly $100 million in profit this year—if the company can hire enough people to help all the seniors calling in with questions.
The goal is to make the products more affordable and accessible—and to reduce Indiana’s high smoking rate. More than 1.1 million adult Hoosiers smoke, and Indiana ranks 44th among states in smoking rate.
Patricia Martin, 58, former chief operating officer of Lilly’s diabetes division, will start her new job July 1, leading an organization that promotes and invests in the state’s life sciences sector.
DowDuPont this month spun off the agricultural chemicals, seeds and plant biotechnology firm, turning it into a standalone public company.
The school said the three-phase project will include construction and renovation of 96,000 square feet of buildings to create a science complex featuring “high-tech classrooms, modern research labs, and collaborative working spaces.”
Hundreds of employees at the Corteva Agriscience Global Business Center in Indianapolis on Monday celebrated the official launch of the company and the first trading of its common stock.
Plans call for the company to spend $11.8 million on the real estate improvements and another $5.7 million on new IT equipment and freezers.
Backed by more than $100 million in funding from Indiana companies and foundations, the Indiana Biosciences Research Institute has hired 39 employees and hopes to ramp up to 80 within another three years.
Endocyte Inc.'s decision two years ago to shelve its own pipeline and look for other opportunities was a difficult call that eventually paid off for investors, its former CEO said Friday at IBJ’s Life Sciences Power Breakfast.
Kansas-based Aratana Therapeutics has three treatments approved by the U.S. Food and Drug Administration and is working on drugs for a range of disease fields, including cancer.
The Carmel startup said its midstage clinical trials met key objectives, an achievement that will it allow to continue developing a technology that measures blood volume and kidney function.
The proposed tax abatement is related to a $91 million investment the company is making in a building at the Lilly Technology Center on Kentucky Avenue.